Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Safety Information For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Tekturna (Aliskiren) Tablets, Novartis Pharma, Approval | Tekturna (aliskiren) Tablets, Novartis Pharma, Labeling Revision | Tekturna HCT (aliskiren/hydrochlorothiazide) Tablets, Novartis Pharma, Approval | Tekturna (aliskiren) Tablets, Novartis Pharma, Labeling Revision | Tekturna (aliskiren hemifumarate) Tablets, Novartis Pharmaceuticals Corp., Labeling Revision | Tekturna HCT (aliskiren hemifumarate/hydrochlorothiazide) Tablets, Novartis Pharma, Labeling Revision | Tekturna HCT (aliskiren hemifumarate and hydrochlorothiazide) Tablets, Novartis Pharmaceuticals Corp., New or Modified Indication | Valturna (aliskiren and valsartan) Tablets, Novartis Pharmaceuticals Corp., Approval | Tekturna (aliskiren hemifumarate) Tablets, Novartis, Labeling Revision | Tekturna HCT (aliskiren hemifumarate and hydrochlorothiazide) Tablets, Novartis Pharmaceuticals Corporation, Labeling Revision | Tekturna (aliskiren hemifumarate) Tablets, Novartis Pharmaceuticals Corporation, Labeling Revision | | Tekturna HCT (aliskiren and hydrochlorothiazide) Tablets, Novartis Pharmaceuticals Corp., Labeling Revision | Valturna (aliskiren hemifumarate and valsartan) Tablets, Novartis Pharmaceuticals, Labeling Revision | Tekamlo (aliskiren and amlodipine) Tablets, Novartis Pharmaceuticals Corp., Approval | Tekturna HCT (aliskiren hemifumarate and hydrochlorothiazide) Tablets, Novartis Pharmaceuticals Corp., Labeling Revision | Tekurna (aliskiren hemifumarate) Tablets, Novartis Pharmaceuticals Corp., Labeling Revision | Valturna (aliskiren hemifumarate and valsartan) Tablets, Novartis Pharmaceuticals Corp., Labeling Revision | Tekamlo (aliskiren hemifumarate and amlodipine besylate) Tablets, Novartis Pharmaceuticals Corp., Labeling Revision | Valturna (aliskiren hemifumarate and valsartan) Tablets, Novartis Pharmaceuticals Corp., Labeling Revision | Tekturna HCT (aliskiren hemifumarate and hydrochlorothiazide) Tablets, Novartis Pharmaceuticals Corp., Labeling Revision | Amturnide (amlodipine besylate, aliskiren hemifumarate and hydrochlorothiazide) Tablets, Novartis Pharmaceuticals Corp., Labeling Revision | Tekamlo, (aliskiren hemifumarate and amlodipine besylate) Tablets, Novartis Pharmaceuticals Corp., Labeling Revision | Tekurna (aliskiren hemifumarate) Tablets, Novartis Pharmaceuticals Corp., Labeling Revision | Tekturna HCT (aliskiren hemifumarate and hydrochlorothiazide) Tablets, Novartis Pharmaceuticals Corp., Labeling Revision | Valturna (aliskiren hemifumarate and valsartan) Tablets, Novartis Pharmaceuticals Corp., Labeling Revision | Tekturna (aliskiren hemifumarate) Tablets, Novartis Pharmaceuticals Corp., Labeling Revision | Amturnide (aliskiren hemifumarate, amlodipine besylate and hydrochlorothiazide) Tablets, Novartis Pharmaceuticals Corp., Labeling Revision | Tekamlo (aliskiren hemifumarate and amlodipine besylate) Tablets, Novartis Pharmaceuticals Corp., Labeling Revision | Tekturna, aliskiren hemifumarate, Tablet; Oral, Novartis, Labeling Revision | Tekamlo, aliskiren hemifumarate; amlodipine besylate, Tablet; Oral, Novartis, Labeling Revision | Amturnide, aliskiren hemifumarate; amlodipine besylate; hydrochlorothiazide, Tablet; Oral, Novartis, Labeling Revision | Tekturna Hct, aliskiren hemifumarate; hydrochlorothiazide, Tablet; Oral, Novartis, Labeling Revision | Valturna, aliskiren hemifumarate; valsartan, Tablet; Oral, Novartis, Labeling Revision | Tekamlo, aliskiren hemifumarate; amlodipine besylate, Tablet; Oral, Novartis, Labeling Revision | Amturnide, aliskiren hemifumarate; amlodipine besylate; hydrochlorothiazide, Tablet; Oral, Novartis, Labeling Revision | Valturna, aliskiren hemifumarate; valsartan, Tablet; Oral, Novartis, Labeling Revision | Amturnide, aliskiren hemifumarate; amlodipine besylate; hydrochlorothiazide, Tablet; Oral, Novartis, Labeling Revision | Tekturna Hct, aliskiren hemifumarate; hydrochlorothiazide, Tablet; Oral, Novartis, Labeling Revision | Tekturna, aliskiren hemifumarate, Tablet; Oral, Novartis, Labeling Revision | Tekamlo, aliskiren hemifumarate; amlodipine besylate, Tablet; Oral, Novartis, Labeling Revision | Amturnide, aliskiren hemifumarate; amlodipine besylate; hydrochlorothiazide, Tablet; Oral, Novartis, Labeling Revision | Tekturna Hct, aliskiren hemifumarate; hydrochlorothiazide, Tablet; Oral, Novartis, Labeling Revision | Valturna, aliskiren hemifumarate; valsartan, Tablet; Oral, Novartis, Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | Best Phone © 2012 Betterchem.com